NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $49,000 | -83.7% | 566 | -86.4% | 0.01% | -87.4% |
| Q1 2016 | $301,000 | +1.3% | 4,159 | +20.7% | 0.09% | -2.2% |
| Q4 2015 | $297,000 | +3.5% | 3,445 | +10.2% | 0.09% | -5.3% |
| Q3 2015 | $287,000 | -5.0% | 3,126 | +1.8% | 0.09% | +4.4% |
| Q2 2015 | $302,000 | +0.3% | 3,072 | +0.6% | 0.09% | -6.2% |
| Q1 2015 | $301,000 | -3.5% | 3,053 | -9.3% | 0.10% | -4.0% |
| Q4 2014 | $312,000 | -1.6% | 3,366 | -0.1% | 0.10% | -6.5% |
| Q3 2014 | $317,000 | +7.8% | 3,370 | +3.8% | 0.11% | +3.9% |
| Q2 2014 | $294,000 | +7.3% | 3,246 | +0.8% | 0.10% | +2.0% |
| Q1 2014 | $274,000 | -1.1% | 3,220 | -6.3% | 0.10% | -3.8% |
| Q4 2013 | $277,000 | +12.1% | 3,438 | +6.8% | 0.10% | 0.0% |
| Q3 2013 | $247,000 | +6.5% | 3,218 | -2.1% | 0.10% | +1.0% |
| Q2 2013 | $232,000 | – | 3,286 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |